VOTIS Subdermal Imaging Technologies

Device for Assessing Foot Patency in People with Peripheral Artery Disease

Startup

VOTIS Subdermal Imaging Technologies is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2017. Device for Assessing Foot Patency in People with Peripheral Artery Disease. The company has raised a total of $8.07M across 6 funding rounds, currently at the A stage. VOTIS Subdermal Imaging Technologies was founded by Merrill Weber. Key investors include Italian Angels for Growth, Siryo SpA . The company has 11-50 employees. Core technologies: Data Storage, Cloud, Platforms & Interfaces, Software, Artificial Intelligence.

With $8.07M in total funding, VOTIS Subdermal Imaging Technologies is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.

$8.07M
Raised
6
Rounds
2
Investors
4
Team
2017
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareMedical Decision SupportData StorageCloudPlatforms & InterfacesSoftwareArtificial Intelligence
At a Glance
Investors
Founders
In the News

7 articles covered by sources including www.prnewswire.com, www.israel21c.org, nocamels.com, globenewswire.com.

www.prnewswire.com · May 2, 2022
VOTIS SUBDERMAL IMAGING TECHNOLOGIES, LTD. ANNOUNCES ENROLLMENT OF FIRST HUMAN SUBJECT IN PILOT FEASIBILITY STUDY OF PEDCHECK™ AT HADASSAH MEDICAL CENTER IN JERUSALEM
Read article ↗
Frequently Asked Questions
What does VOTIS Subdermal Imaging Technologies do?

VOTIS Subdermal Imaging Technologies is developing a suite of devices designed to help people with peripheral artery disease (PAD) preserve their feet. The companys PedCheck is used to screen the feet of asymptomatic patients for PAD. If PAD is found, then the PedStage will be used to stage and monitor disease progression and the impact of therapies prescribed by the patients physician. The PedFlo can be used during a revascularization procedure to inform the physician about the level of blood flow in the foot. All three VOTIS devices are safe, noninvasive, and free of ionizing radiation.

How much funding has VOTIS Subdermal Imaging Technologies raised?

VOTIS Subdermal Imaging Technologies has raised $8.07M in total funding across 6 rounds. The company is currently at the A stage. Key investors include Italian Angels for Growth, Siryo SpA .

Who founded VOTIS Subdermal Imaging Technologies?

VOTIS Subdermal Imaging Technologies was founded in 2017 by Merrill Weber (Co-founder & CEO).

What sector is VOTIS Subdermal Imaging Technologies in?

VOTIS Subdermal Imaging Technologies operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, Digital Healthcare, Medical Decision Support, with core technologies in Data Storage, Cloud, Platforms & Interfaces, Software, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is VOTIS Subdermal Imaging Technologies located?

VOTIS Subdermal Imaging Technologies is based in Dostai Street 3, Jerusalem, Israel, Jerusalem District.

View Full Profile Classic View Website ↗